{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"The primary endpoint for safety analysis and monitoring is toxic death, which is death primarily attributable to treatment.","groups":[{"description":"All Patients","id":"OG000","title":"Group 1"}],"paramType":"NUMBER","populationDescription":"The six patients who received induction and reported death. The analysis here examines whether their death is primarily attributable to treatment or not.","reportingStatus":"POSTED","timeFrame":"Within 30 days of protocol treatment at median follow-up of 48 months (range: 1 to 70 months).","title":"Safety Analysis and Monitoring of Toxic Death","type":"PRIMARY","unitOfMeasure":"participants"}